{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:13:42Z","timestamp":1789193622515,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI048638; R37 DK057665; U19 AI057266; U19 AI090023"],"award-info":[{"award-number":["R01 AI048638; R37 DK057665; U19 AI057266; U19 AI090023"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adjuvants hold great potential in enhancing vaccine efficacy, making the understanding and improving of adjuvants critical goals in vaccinology. The TLR7\/8 agonist, 3M-052, induces long-lived humoral immunity in non-human primates and is currently being evaluated in human clinical trials. However, the innate mechanisms of 3M-052 have not been fully characterized. Here, we perform flow cytometry, single cell RNA-seq and ATAC-seq to profile the kinetics, transcriptomics and epigenomics of innate immune cells in murine draining lymph nodes following 3M-052-Alum\/Ovalbumin immunization. We find that 3M-052-Alum\/OVA induces a robust antiviral and interferon gene program, similar to the yellow fever vaccine, which is known to confer long-lasting protection. Activation of myeloid cells in dLNs persists through day 28 and single cell analysis reveals putative TF-gene regulatory programs in distinct myeloid cells and heterogeneity of monocytes. This study provides a comprehensive characterization of the transcriptomics and epigenomics of innate populations in the dLNs after vaccination.<\/jats:p>","DOI":"10.1038\/s41467-022-28197-9","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T11:03:15Z","timestamp":1643281395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice"],"prefix":"10.1038","volume":"13","author":[{"given":"Audrey","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine K. D.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wimmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0090-5689","authenticated-orcid":false,"given":"Prabhu S.","family":"Arunachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2826-1723","authenticated-orcid":false,"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Tomai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purvesh","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6517-4333","authenticated-orcid":false,"given":"Bali","family":"Pulendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"28197_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","volume":"33","author":"RL Coffman","year":"2010","unstructured":"Coffman, R. L., Sher, A. & Seder, R. A. Vaccine adjuvants: Putting innate immunity to work. Immunity 33, 492\u2013503 (2010).","journal-title":"Immunity"},{"key":"28197_CR2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.drudis.2009.02.009","volume":"14","author":"DT O\u2019Hagan","year":"2009","unstructured":"O\u2019Hagan, D. T. & De Gregorio, E. The path to a successful vaccine adjuvant \u2014\u2018The long and winding road\u2019. Drug Discov. Today 14, 541\u2013551 (2009).","journal-title":"Drug Discov. Today"},{"key":"28197_CR3","doi-asserted-by":"publisher","unstructured":"Pulendran, B. & Arunachalam, P. S. Emerging concepts in the science of vaccine adjuvants. Nat. Rev. Drug Discov. https:\/\/doi.org\/10.1038\/s41573-021-00163-y (2021).","DOI":"10.1038\/s41573-021-00163-y"},{"key":"28197_CR4","doi-asserted-by":"publisher","unstructured":"Pulendran, B. & Ahmed, R. Translating innate immunity into immunological memory: Implications for vaccine development. Cell https:\/\/doi.org\/10.1016\/j.cell.2006.02.019 (2006).","DOI":"10.1016\/j.cell.2006.02.019"},{"key":"28197_CR5","first-page":"942","volume":"52","author":"SL Nutt","year":"2020","unstructured":"Nutt, S. L. & Chopin, M. Transcriptional networks driving dendritic. Cell Differentiation Funct. Immunity 52, 942\u2013956 (2020).","journal-title":"Cell Differentiation Funct. Immunity"},{"key":"28197_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.0105-2896.2004.00144.x","volume":"199","author":"B Pulendran","year":"2004","unstructured":"Pulendran, B. Modulating vaccine responses with dendritic cells and toll-like receptors. Immunol. Rev. 199, 227\u2013250 (2004).","journal-title":"Immunol. Rev."},{"key":"28197_CR7","doi-asserted-by":"publisher","unstructured":"Kasturi, S. P. et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature https:\/\/doi.org\/10.1038\/nature09737 (2011).","DOI":"10.1038\/nature09737"},{"key":"28197_CR8","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1126\/science.1138963","volume":"316","author":"V Mata-Haro","year":"2007","unstructured":"Mata-Haro, V. et al. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316, 1628\u20131632 (2007).","journal-title":"Science"},{"key":"28197_CR9","doi-asserted-by":"crossref","unstructured":"Kasturi, S. P. et al. Adjuvanting a simian immunodeficiency virus vaccine with Toll-like receptor ligands encapsulated in nanoparticles. J. Virol. 91, 1\u201325 (2017).","DOI":"10.1128\/JVI.01844-16"},{"key":"28197_CR10","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/jama.2018.1097","volume":"319","author":"HBV Infection","year":"2018","unstructured":"Infection, H. B. V., Effects, A., Vaccines, T. & Studies, C. A two-dose hepatitis B vaccine for adults (Heplisav-B). JAMA\u2014J. Am. Med. Assoc. 319, 822\u2013823 (2018).","journal-title":"JAMA"},{"key":"28197_CR11","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/S0140-6736(20)32014-6","volume":"396","author":"BJ Ward","year":"2020","unstructured":"Ward, B. J. et al. Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18\u201364 years) and older adults (\u226565 years): two multicentre, randomised phase 3 trials. Lancet 396, 1491\u20131503 (2020).","journal-title":"Lancet"},{"key":"28197_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41586-021-03530-2","volume":"594","author":"PS Arunachalam","year":"2021","unstructured":"Arunachalam, P. S. et al. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity. Nature 594, 253\u2013258 (2021).","journal-title":"Nature"},{"key":"28197_CR13","doi-asserted-by":"crossref","unstructured":"Catteau, G., Geeraerts, B. & Descamps, D. Sustained efficacy, immunogenicity, and safety of the HPV-16\/18 AS04-adjuvanted vaccine. Final analysis of a long-term follow-up study up to 9. 4 years. Hum. Vaccin. Immunother. 10, 2147\u20132162 (2014).","DOI":"10.4161\/hv.29532"},{"key":"28197_CR14","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1182\/blood-2011-10-388579","volume":"119","author":"M Kwissa","year":"2012","unstructured":"Kwissa, M., Nakaya, H. I., Oluoch, H. & Pulendran, B. Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates. Blood 119, 2044\u20132055 (2012).","journal-title":"Blood"},{"key":"28197_CR15","doi-asserted-by":"publisher","first-page":"e91020","DOI":"10.1172\/jci.insight.91020","volume":"2","author":"DJ Dowling","year":"2017","unstructured":"Dowling, D. J. et al. TLR7\/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth. JCI insight 2, e91020 (2017).","journal-title":"JCI insight"},{"key":"28197_CR16","doi-asserted-by":"publisher","unstructured":"Petitdemange, C., Masopust, D. & Pulendran, B. Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.126047 (2019).","DOI":"10.1172\/jci.insight.126047"},{"key":"28197_CR17","doi-asserted-by":"crossref","unstructured":"Kasturi, S. P. et al. 3M-052, a synthetic TLR-7\/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates. Sci. Immunol. 5, eabb1025 (2020).","DOI":"10.1126\/sciimmunol.abb1025"},{"key":"28197_CR18","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s41591-020-0858-8","volume":"26","author":"PS Arunachalam","year":"2020","unstructured":"Arunachalam, P. S. et al. T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers. Nat. Med. 26, 932\u2013940 (2020).","journal-title":"Nat. Med."},{"key":"28197_CR19","doi-asserted-by":"crossref","unstructured":"Liang, F. et al. Vaccine priming is restricted to draining lymph nodes & controlled by adjuvant-mediated antigen uptake. Sci. Transl. Med. 9, eaal2094 (2017).","DOI":"10.1126\/scitranslmed.aal2094"},{"key":"28197_CR20","doi-asserted-by":"crossref","unstructured":"Liang, F. & Lor\u00e9, K. Local innate immune responses in the vaccine adjuvant-injected muscle. Clin. Transl. Immunol. 5, e74 (2016).","DOI":"10.1038\/cti.2016.19"},{"key":"28197_CR21","first-page":"269","volume":"88","author":"World Health Organization.","year":"2013","unstructured":"World Health Organization. Weekly epidemiological record. WHO Position Pap. No. 27 88, 269\u2013284 (2013).","journal-title":"WHO Position Pap. No. 27"},{"key":"28197_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","volume":"64","author":"TP Monath","year":"2015","unstructured":"Monath, T. P. & Vasconcelos, P. F. C. Yellow fever. J. Clin. Virol. 64, 160\u2013173 (2015).","journal-title":"J. Clin. Virol."},{"key":"28197_CR23","doi-asserted-by":"publisher","unstructured":"Pulendran, B. Learning immunology from the yellow fever vaccine: Innate immunity to systems vaccinology. Nat. Rev. Immunol. https:\/\/doi.org\/10.1038\/nri2629 (2009)","DOI":"10.1038\/nri2629"},{"key":"28197_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ni.1688","volume":"10","author":"TD Querec","year":"2009","unstructured":"Querec, T. D. et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10, 116\u2013125 (2009).","journal-title":"Nat. Immunol."},{"key":"28197_CR25","doi-asserted-by":"crossref","unstructured":"Akondy, R. S., Johnson, P. L. F., Nakaya, H. I., Edupuganti, S. & Mulligan, M. J. Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination. Proc. Natl Acad. Sci. USA 112, 1\u20136 (2015).","DOI":"10.1073\/pnas.1500475112"},{"key":"28197_CR26","doi-asserted-by":"publisher","unstructured":"Miller, J. D. et al. Article human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity https:\/\/doi.org\/10.1016\/j.immuni.2008.02.020 (2008).","DOI":"10.1016\/j.immuni.2008.02.020"},{"key":"28197_CR27","doi-asserted-by":"publisher","unstructured":"Querec, T. et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20051720 (2006).","DOI":"10.1084\/jem.20051720"},{"key":"28197_CR28","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","volume":"183","author":"RS Akondy","year":"2009","unstructured":"Akondy, R. S. et al. The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J. Immunol. 183, 7919\u20137930 (2009).","journal-title":"J. Immunol."},{"key":"28197_CR29","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1084\/jem.20082292","volume":"205","author":"D Gaucher","year":"2008","unstructured":"Gaucher, D. et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205, 3119\u20133131 (2008).","journal-title":"J. Exp. Med."},{"key":"28197_CR30","doi-asserted-by":"publisher","unstructured":"Neill, L. A. J. O. & Netea, M. G. BCG-induced trained immunity: Can it offer protection against COVID-19? Nat. Rev. Immunol. https:\/\/doi.org\/10.1038\/s41577-020-0337-y (2020).","DOI":"10.1038\/s41577-020-0337-y"},{"key":"28197_CR31","doi-asserted-by":"crossref","unstructured":"Netea, M. G. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375\u2013388 (2020).","DOI":"10.1038\/s41577-020-0285-6"},{"key":"28197_CR32","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1016\/j.cell.2021.05.039","volume":"184","author":"F Wimmers","year":"2021","unstructured":"Wimmers, F. et al. The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination. Cell 184, 3915\u20133935.e21 (2021).","journal-title":"Cell"},{"key":"28197_CR33","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/ni.2370","volume":"13","author":"JC Miller","year":"2012","unstructured":"Miller, J. C. et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat. Immunol. 13, 888\u2013899 (2012).","journal-title":"Nat. Immunol."},{"key":"28197_CR34","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1016\/j.celrep.2019.11.042","volume":"29","author":"R Leylek","year":"2019","unstructured":"Leylek, R. et al. Integrated cross-species analysis identifies a conserved transitional dendritic cell population. Cell Rep. 29, 3736\u20133750.e8 (2019).","journal-title":"Cell Rep."},{"key":"28197_CR35","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cell.2019.09.035","volume":"179","author":"CC Brown","year":"2019","unstructured":"Brown, C. C. et al. Transcriptional basis of mouse and human dendritic cell heterogeneity. Cell 179, 846\u2013863.e24 (2019).","journal-title":"Cell"},{"key":"28197_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins, J. W. et al. A diverse range of gene products are effectors of the type i interferon antiviral response. Nature 472, 481\u2013485 (2011).","journal-title":"Nature"},{"key":"28197_CR37","first-page":"2002","volume":"3","author":"M Jurk","year":"2002","unstructured":"Jurk, M. et al. Human TLR7 or TLR8 independently confer responsiveness to the. Nature 3, 2002 (2002).","journal-title":"Nature"},{"key":"28197_CR38","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.4049\/jimmunol.177.10.6584","volume":"177","author":"KKB Gorden","year":"2006","unstructured":"Gorden, K. K. B., Qiu, X. X., Binsfeld, C. C. A., Vasilakos, J. P. & Alkan, S. S. Cutting edge: Activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides. J. Immunol. 177, 6584\u20136587 (2006).","journal-title":"J. Immunol."},{"key":"28197_CR39","unstructured":"Iannitti, R. G. et al. IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis. Nat. Commun. 7, 10791 (2016)."},{"key":"28197_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2015.00416","volume":"6","author":"N von Burg","year":"2015","unstructured":"von Burg, N., Turchinovich, G. & Finke, D. Maintenance of immune homeostasis through ILC\/T cell interactions. Front. Immunol. 6, 1\u201313 (2015).","journal-title":"Front. Immunol."},{"key":"28197_CR41","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.immuni.2017.04.018","volume":"46","author":"A Mildner","year":"2017","unstructured":"Mildner, A. et al. Genomic characterization of murine monocytes reveals C\/EBP\u03b2 transcription factor dependence of Ly6C\u2212 cells. Immunity 46, 849\u2013862.e7 (2017).","journal-title":"Immunity"},{"key":"28197_CR42","doi-asserted-by":"publisher","unstructured":"Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. https:\/\/doi.org\/10.1038\/ni.2789 (2014).","DOI":"10.1038\/ni.2789"},{"key":"28197_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4049\/jimmunol.181.1.17","volume":"181","author":"H Li","year":"2008","unstructured":"Li, H., Willingham, S. B., Ting, J. P.-Y. & Re, F. Cutting edge: Inflammasome activation by alum and alum\u2019s adjuvant effect are mediated by NLRP3. J. Immunol. 181, 17\u201321 (2008).","journal-title":"J. Immunol."},{"key":"28197_CR44","doi-asserted-by":"publisher","unstructured":"Mckee, A. S. et al. Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells. Proc. Natl Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.1300392110 (2013).","DOI":"10.1073\/pnas.1300392110"},{"key":"28197_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0081953","volume":"8","author":"PCC Neves","year":"2013","unstructured":"Neves, P. C. C., Santos, J. R., Tubar\u00e3o, L. N., Bonaldo, M. C. & Galler, R. Early IFN-gamma production after YF 17D vaccine virus immunization in mice and its association with adaptive immune responses. PLoS One 8, 1\u201316 (2013).","journal-title":"PLoS One"},{"key":"28197_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-56994-8","volume":"9","author":"J Weiner","year":"2019","unstructured":"Weiner, J. et al. Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: Randomized controlled clinical trials conducted by the BIOVACSAFE consortium. Sci. Rep. 9, 1\u201314 (2019).","journal-title":"Sci. Rep."},{"key":"28197_CR47","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41588-021-00790-6","volume":"53","author":"JM Granja","year":"2021","unstructured":"Granja, J. M. et al. Author Correction: ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis. Nat. Genet. 53, 403\u2013411 https:\/\/doi.org\/10.1038\/s41588-021-00790-6Nat. Genet. 53, 935 (2021).","journal-title":"Nat. Genet."},{"key":"28197_CR48","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nmeth.4401","volume":"14","author":"AN Schep","year":"2017","unstructured":"Schep, A. N., Wu, B., Buenrostro, J. D. & Greenleaf, W. J. ChromVAR: Inferring transcription-factor-associated accessibility from single-cell epigenomic data. Nat. Methods 14, 975\u2013978 (2017).","journal-title":"Nat. Methods"},{"key":"28197_CR49","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","volume":"46","author":"H Han","year":"2018","unstructured":"Han, H. et al. TRRUST v2: An expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 46, D380\u2013D386 (2018).","journal-title":"Nucleic Acids Res."},{"key":"28197_CR50","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.cell.2018.03.074","volume":"173","author":"JD Buenrostro","year":"2018","unstructured":"Buenrostro, J. D. et al. Integrated single-cell analysis maps the continuous regulatory landscape of human hematopoietic differentiation. Cell 173, 1535\u20131548.e16 (2018).","journal-title":"Cell"},{"key":"28197_CR51","doi-asserted-by":"publisher","unstructured":"Quintin, J. et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe https:\/\/doi.org\/10.1016\/j.chom.2012.06.006 (2012).","DOI":"10.1016\/j.chom.2012.06.006"},{"key":"28197_CR52","doi-asserted-by":"publisher","unstructured":"Saeed, S. et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science https:\/\/doi.org\/10.1126\/science.1251086 (2014).","DOI":"10.1126\/science.1251086"},{"key":"28197_CR53","doi-asserted-by":"publisher","unstructured":"Arts, R. J. W. et al. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2016.10.008 (2016).","DOI":"10.1016\/j.cmet.2016.10.008"},{"key":"28197_CR54","doi-asserted-by":"publisher","unstructured":"Kleinnijenhuis, J. et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc. Natl. Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.1202870109 (2012).","DOI":"10.1073\/pnas.1202870109"},{"key":"28197_CR55","doi-asserted-by":"publisher","unstructured":"Arts, R. J. W. et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe https:\/\/doi.org\/10.1016\/j.chom.2017.12.010 (2018).","DOI":"10.1016\/j.chom.2017.12.010"},{"key":"28197_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.00001","volume":"10","author":"HSen Chiang","year":"2019","unstructured":"Chiang, H. Sen & Liu, H. M. The molecular basis of viral inhibition of IRF- and STAT-dependent immune responses. Front. Immunol. 10, 1\u201311 (2019).","journal-title":"Front. Immunol."},{"key":"28197_CR57","doi-asserted-by":"crossref","unstructured":"Ma, F. et al. Retinoid X receptor \u03b1 attenuates host antiviral response by suppressing type I interferon. Nat. Commun. 5, 5494 (2014).","DOI":"10.1038\/ncomms6494"},{"key":"28197_CR58","doi-asserted-by":"publisher","first-page":"10626","DOI":"10.1073\/pnas.0913545107","volume":"107","author":"V N\u00fa\u00f1ez","year":"2010","unstructured":"N\u00fa\u00f1ez, V. et al. Retinoid X receptor \u03b1 controls innate inflammatory responses through the up-regulation of chemokine expression. Proc. Natl. Acad. Sci. USA 107, 10626\u201310631 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"28197_CR59","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.4049\/jimmunol.173.5.2952","volume":"173","author":"I Dzhagalov","year":"2004","unstructured":"Dzhagalov, I., Gigu\u00e8re, V. & He, Y.-W. Lymphocyte development and function in the absence of retinoic acid-related orphan receptor \u03b1. J. Immunol. 173, 2952\u20132959 (2004).","journal-title":"J. Immunol."},{"key":"28197_CR60","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.celrep.2017.08.023","volume":"20","author":"A Rechtien","year":"2017","unstructured":"Rechtien, A. et al. Systems vaccinology identifies an early innate immune signature as a correlate of antibody responses to the ebola vaccine rVSV-ZEBOV. Cell Rep. 20, 2251\u20132261 (2017).","journal-title":"Cell Rep."},{"key":"28197_CR61","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nri2359","volume":"8","author":"DJ Todd","year":"2008","unstructured":"Todd, D. J., Lee, A. H. & Glimcher, L. H. The endoplasmic reticulum stress response in immunity and autoimmunity. Nat. Rev. Immunol. 8, 663\u2013674 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"28197_CR62","doi-asserted-by":"publisher","unstructured":"Lau, C. M. et al. Epigenetic control of innate and adaptive immune memory. Nat. Immunol. https:\/\/doi.org\/10.1038\/s41590-018-0176-1 (2018).","DOI":"10.1038\/s41590-018-0176-1"},{"key":"28197_CR63","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nri3671","volume":"14","author":"F Ginhoux","year":"2014","unstructured":"Ginhoux, F. & Jung, S. Monocytes and macrophages: Developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 14, 392\u2013404 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"28197_CR64","doi-asserted-by":"publisher","unstructured":"Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity https:\/\/doi.org\/10.1016\/j.immuni.2012.12.001 (2013).","DOI":"10.1016\/j.immuni.2012.12.001"},{"key":"28197_CR65","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4049\/jimmunol.161.2.1045","volume":"161","author":"DF Hoft","year":"1998","unstructured":"Hoft, D. F., Brown, R. M. & Roodman, S. T. Bacille Calmette-Gu\u00e9rin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype. J. Immunol. 161, 1045\u20131054 (1998).","journal-title":"J. Immunol."},{"key":"28197_CR66","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1038\/s41421-019-0114-x","volume":"5","author":"F Zhang","year":"2019","unstructured":"Zhang, F., Wu, Y. & Tian, W. A novel approach to remove the batch effect of single-cell data. Cell Discov. 5, 0\u20133 (2019).","journal-title":"Cell Discov."},{"key":"28197_CR67","doi-asserted-by":"crossref","unstructured":"Khatri, P., Sirota, M. & Butte, A. J. Ten years of pathway analysis: Current approaches and outstanding challenges. PLoS Comput. Biol. 8, e1002375 (2012).","DOI":"10.1371\/journal.pcbi.1002375"},{"key":"28197_CR68","first-page":"144","volume":"0","author":"WA Haynes","year":"2017","unstructured":"Haynes, W. A. et al. Empowering multi-cohort gene expression analysis to increase reproducibility. Pacific Symp. Biocomput. 0, 144\u2013153 (2017).","journal-title":"Pacific Symp. Biocomput."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28197-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28197-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28197-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T22:52:27Z","timestamp":1674600747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28197-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["28197"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-28197-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"assertion":[{"value":"23 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.P. serves on the External Immunology Board of GlaxoSmithKline, and on the Scientific Advisory Board of Medicago. M.T. is an employee of 3M, the manufacturer of 3M-052-Alum used in this study. C.B.F. is an inventor on a patent application regarding the 3M-052-Alum formulation. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"549"}}